시장보고서
상품코드
1514100

세계의 인공눈물 시장

Artificial Tears

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 277 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 인공눈물 시장은 2030년까지 53억 달러에 달할 전망

2023년에 35억 달러로 평가된 세계의 인공눈물 시장은 분석 기간 2023년부터 2030년까지 CAGR 6.1%로 성장할 전망이며, 2030년에는 53억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 글리콜 기반 인공눈물은 CAGR 5.5%로 성장을 지속하고, 분석 기간 종료 시 27억 달러에 달할 것으로 예측됩니다. 셀룰로오스 기반 인공눈물 분야의 성장률은 분석 기간 동안 CAGR 6.3%로 추정됩니다.

미국 시장은 9억 1,930만 달러, 중국은 CAGR 9.5%로 성장 예측

미국의 인공눈물 시장은 2023년 9억 1,930만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 13억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 9.5%로 전망됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.3%와 4.7%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 4.1%로 성장할 것으로 예측됩니다.

세계의 인공눈물 시장-주요 동향 및 촉진요인 정리

안구건조증(DED)은 미국에서 공중위생상의 심각한 우려사항으로 인식되고 있으며, 진단을 받고 있는 환자는 추정 1,600만명, 진단을 받지 않은 환자는 더욱 수백만명에 이를 것으로 간주됩니다. 눈물, 빛에 대한 과민성, 작열감 등의 증상은 생활의 질을 저하시킬 뿐만 아니라, 치료나 일의 생산성 저하에 의한 경제적 부담도 큽니다. DED는 주로 방수 결핍형과 증발형의 2가지 유형이 있으며, 후자는 저습도 등의 환경 요인이나 눈꺼풀의 횟수를 줄이고 눈물의 증발을 증가시키는 디지털 기기의 장시간 사용 등의 라이프 스타일 선택으로 악화됩니다. DED를 앓고 있는 층은 청소년층으로 퍼져 있는데, 이는 화면에 노출이 증가했기 때문입니다. 여성은 특히 DED에 걸리기 쉽고 호르몬 변동이 눈물 분비에 영향을 미치는 경우가 많기 때문에 남성에 비해 유병률이 높고 심각한 영향을 미칩니다.

인공눈물은 증상을 완화하고 눈의 자연적인 수분층을 보완함으로써 DED의 관리에 빠뜨릴 수 없는 치료가 됩니다. 이러한 시판 제품은 일반적으로 카르복시메틸셀룰로오스 및 히드록시메틸셀룰로오스와 같은 체중 감량제를 포함하며 눈 표면의 수분을 유지하는 데 도움이 됩니다. 미네랄 오일과 같은 에몰리언트제는 눈물막의 지질층을 강화하기 위해 증발을 억제하고 증발성 DED의 일반적인 원인인 마이보미아 선기능 장애를 가진 사람에게 유익한 제형에 첨가됩니다. 그러나 많은 인공눈물에는 박테리아의 번식을 방지하기 위한 방부제가 포함되어 있지만, 특히 자주 사용하는 경우 자극을 유발할 수 있으므로 더 안전하고 자주 사용할 수 있도록 1회분씩 바이알에 포장된 방부제 프리 제품을 선호하는 소비자가 늘고 있습니다.

인공눈물 수요는 세계의 스크린 사용 증가 및 노화와 같은 안구건조증의 만연으로 이어지는 몇 가지 요인에 의해 견인되고 있습니다. 게다가, 소비자의 의식 증가와 건강 관리에 대한 권고는 인공눈물로 인한 셀프 메디케이션을 지원하고, 자극을 피하기 위해 방부제가 없는 제제로의 전환이 두드러집니다. 오염이나 공기 조절이 가능한 실내 등 환경의 변화도 안구건조증의 증상을 악화시켜 시장의 성장을 더욱 촉진하고 있습니다. 이러한 요인 외에도 콘택트렌즈의 장기 착용과 패션의 영향과 같은 라이프 스타일의 동향도 눈 건강 관리에서 인공눈물의 지속적인 관련성과 확대를 확실히하고 있습니다.

조사 대상 기업 예(총 49건)

  • Abbott Medical Optics Inc.
  • Akorn, Inc.
  • Allergan, Inc.
  • Bausch & Lomb Inc.
  • Johnson & Johnson
  • Novartis International AG

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.07.24

Global Artificial Tears Market to Reach US$5.3 Billion by 2030

The global market for Artificial Tears estimated at US$3.5 Billion in the year 2023, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Glycol-based Artificial Tears, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Cellulose-based Artificial Tears segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$919.3 Million While China is Forecast to Grow at 9.5% CAGR

The Artificial Tears market in the U.S. is estimated at US$919.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 9.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Artificial Tears Market - Key Trends and Drivers Summarized

Dry Eye Disease (DED), increasingly recognized as a significant public health concern in the United States, affects an estimated 16 million diagnosed individuals, with millions more likely suffering undiagnosed. Symptoms such as watery eyes, sensitivity to light, and a burning sensation not only degrade quality of life but also impose substantial economic costs due to treatment and reduced work productivity. DED occurs in two primary forms: aqueous-deficient and evaporative, the latter being exacerbated by environmental factors like low humidity and lifestyle choices such as prolonged use of digital devices, which reduce blinking rates and increase tear evaporation. The demographic affected by DED is broadening to include younger individuals, attributed to heightened exposure to screens. Women are particularly more prone to DED, with hormonal fluctuations often influencing tear production and leading to higher prevalence and more severe impacts compared to men.

Artificial tears serve as an essential treatment for managing DED by providing symptomatic relief and supplementing the eye's natural moisture layer. These over-the-counter products typically contain demulcents like carboxymethylcellulose or hydroxymethylcellulose, which help maintain ocular surface moisture. Emollients such as mineral oil are added to some formulations to enhance the lipid layer of the tear film, thus reducing evaporation and benefiting those with Meibomian Gland Dysfunction, a common cause of evaporative DED. However, while many artificial tears contain preservatives to prevent bacterial growth, these can cause irritation, especially with frequent use, leading to a growing consumer preference for preservative-free options packaged in single-dose vials for safer, more frequent application.

The demand for artificial tears is driven by several factors, including the global increase in screen use and an aging population, both of which contribute to the prevalence of dry eye symptoms. Additionally, growing consumer awareness and healthcare recommendations support self-medication with artificial tears, with a notable shift towards preservative-free formulations to avoid irritation. Environmental changes such as pollution and air-conditioned interiors also exacerbate dry eye symptoms, further propelling the market growth. These factors, along with lifestyle trends like the extended wear of contact lenses and the influence of fashion, ensure the continued relevance and expansion of artificial tears in managing eye health.

Select Competitors (Total 49 Featured) -

  • Abbott Medical Optics Inc.
  • Akorn, Inc.
  • Allergan, Inc.
  • Bausch & Lomb Inc.
  • Johnson & Johnson
  • Novartis International AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Dry Eyes - A Lucrative Segment of Ophthalmology Market
    • Recent Market Activity
    • Artificial Tears: The First Line and Mainstay Treatment for Dry Eyes
    • Other Therapies for Dry Eye
    • Current & Future Analysis
    • Developing Countries Display Strong Growth Prospects
    • Under-reporting of DES Condition Stifles Market Opportunities
    • Prevalence and Incidence of Dry Eye Syndrome
    • Select Stats on Prevalence Rates
    • Concentrated Prescription Dry Eye Products Market Benefits OTC Market
    • Artificial Tears - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Dry Eye Syndrome Globally Drives Demand for Artificial Tears
    • Aging Population and Associated Eye Health Concerns Boost Product Use
    • Innovations in Preservative-Free Formulations to Enhance Safety and Comfort
    • Expansion of Screen Time Due to Increased Use of Digital Devices
    • Growing Awareness and Diagnosis of Eye Health Issues
    • Development of Multi-Dose and Single-Dose Solutions Tailored to User Needs
    • Increasing Preference for Over-the-Counter Eye Care Products
    • Integration of Natural and Organic Components in Artificial Tear Formulations
    • Technological Advances in Packaging and Dispensing Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glycol-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glycol-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Glycol-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cellulose-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cellulose-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cellulose-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Eye Drops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Eye Drops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Eye Drops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ointments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ointments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ointments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Dry Eye Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Dry Eye Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Dry Eye Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Infections & Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Infections & Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Infections & Allergies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Artificial Tears Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Artificial Tears by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Artificial Tears by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Artificial Tears by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Artificial Tears by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Artificial Tears Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Artificial Tears by Chemistry - Glycol-based, Cellulose-based and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Artificial Tears by Chemistry - Percentage Breakdown of Value Sales for Glycol-based, Cellulose-based and Other Types for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Artificial Tears by Delivery Method - Eye Drops and Ointments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Artificial Tears by Delivery Method - Eye Drops and Ointments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Artificial Tears by Delivery Method - Percentage Breakdown of Value Sales for Eye Drops and Ointments for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Artificial Tears by Application - Dry Eye Syndrome, Infections & Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Artificial Tears by Application - Percentage Breakdown of Value Sales for Dry Eye Syndrome, Infections & Allergies and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제